NIH-funded research R01 grant

Understanding Lung Disease in Rheumatoid Arthritis

Official title: Rheumatoid Arthritis-Related Autoantibodies, Articular Inflammation, and RA-Associated Interstitial Lung Disease

Funded at Brigham and Women's Hospital · NIH-11123190 · Data updated 2026-11-12

This project looks at how specific markers in the blood and joint inflammation might connect to lung problems in adults with rheumatoid arthritis.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionBrigham and Women's Hospital
NIH-funded
Lab location1 site (Boston, United States)
Project startSeptember 27, 2021
Project endJune 30, 2026
Funding year2025
Award (this year)$694,961
NIH project number5R01AR077607-05
Project IDNIH-11123190 on NIH RePORTER

Who could benefit from this research

Could help

This research is relevant for adults aged 21 and older who have rheumatoid arthritis, especially those with specific autoantibodies or concerns about lung health.

Less likely to help

Patients without rheumatoid arthritis or those not at risk for interstitial lung disease may not directly benefit from this specific research.

What this research studies

Rheumatoid arthritis (RA) can cause painful joint inflammation and sometimes a serious lung condition called interstitial lung disease (ILD). Our team is exploring if certain blood markers, called autoantibodies, and the level of joint inflammation can help predict who might develop RA-ILD. We believe that issues starting in the lungs, possibly due to factors like smoking, might lead to these autoantibodies forming even before joint symptoms appear. This work aims to understand how these different aspects of RA are linked throughout the disease.

Why it matters

Potential benefit: If successful, this work could help identify patients with rheumatoid arthritis who are at higher risk for developing serious lung complications, allowing for earlier detection and potentially better management.

How similar studies have gone: Previous studies have suggested a link between these autoantibodies and RA-ILD, and this work builds upon that understanding to explore predictive factors.

Where this research is happening

  • Brigham and Women's Hospital
    Boston, United States
    Active

Researchers

  • Principal investigator: Sparks, Jeffrey Andrew — Brigham and Women's Hospital
  • Study coordinator: Sparks, Jeffrey Andrew

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.